NASDAQ:SNSE
Sensei Biotherapeutics, Inc.
- Stock
Last Close
1.51
13/05 20:00
Market Cap
20.00M
Beta: −0.20
Volume Today
225.91K
Avg: 84.31K
PE Ratio
−0.55
PFCF: −0.57
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -13.04M - | -16.74M 28.38% | -20.10M 20.07% | -36.79M 83.05% | -48.59M 32.05% | -34.10M 29.82% | |
depreciation and amortization | 44K - | 73K 65.91% | 209K 186.30% | 685K 227.75% | 1.35M 96.64% | 571K 57.61% | |
deferred income tax | 1.97M - | -1.04M 152.71% | 19K 101.83% | 2.33M - | |||
stock based compensation | 1.19M - | 1.18M 1.34% | 1.49M 26.87% | 5.66M 279.16% | 5.81M 2.74% | 4.45M 23.37% | |
change in working capital | 1.49M - | 3.47M 132.82% | -397K 111.44% | 117K 129.47% | 1.01M 761.54% | -4.33M 529.56% | |
accounts receivables | |||||||
inventory | |||||||
accounts payables | 931K - | 2.34M 151.56% | 335K 85.70% | -1.43M 525.67% | 2.02M 241.44% | -2.33M 215.57% | |
other working capital | 559K - | 1.13M 101.61% | -732K 164.95% | 1.54M 310.79% | -1.01M 165.39% | -2.00M 98.12% | |
other non cash items | 1.48M - | 2.13M 44.18% | 57K 97.33% | 1.40M 2,347.37% | -948K 167.96% | ||
net cash provided by operating activities | -10.31M - | -8.57M 16.89% | -17.70M 106.57% | -30.26M 70.91% | -39.03M 28.97% | -32.02M 17.94% | |
investments in property plant and equipment | -31K - | -53K 70.97% | -1.21M 2,175.47% | -2.03M 67.99% | -321K 84.16% | -180K 43.93% | |
acquisitions net | -197K - | 318K 261.42% | 15K 95.28% | 166K 1,006.67% | |||
purchases of investments | -183.67M - | -46.87M 74.48% | -21.15M 54.88% | ||||
sales maturities of investments | 42.26M - | 97.12M 129.83% | 59.58M 38.66% | ||||
other investing activites | |||||||
net cash used for investing activites | -31K - | -53K 70.97% | -1.40M 2,547.17% | -143.12M 10,100.86% | 49.95M 134.90% | 38.41M 23.10% | |
debt repayment | -27K - | -41K 51.85% | -255K 521.95% | -629K 146.67% | -761K 20.99% | ||
common stock issued | 154K - | 541K 251.30% | 140.59M 25,887.80% | 238K 99.83% | 48K 79.83% | ||
common stock repurchased | -10.38M - | ||||||
dividends paid | |||||||
other financing activites | 750K - | 8.10M 979.33% | 34.95M 331.79% | 23.60M 32.48% | 104K 99.56% | -76K 173.08% | |
net cash used provided by financing activities | 750K - | 8.22M 996.27% | 35.45M 331.20% | 163.94M 362.42% | -287K 100.18% | -11.17M 3,793.03% | |
effect of forex changes on cash | |||||||
net change in cash | -9.59M - | -402K 95.81% | 16.34M 4,165.92% | -9.44M 157.74% | 10.64M 212.71% | -4.78M 144.98% | |
cash at beginning of period | 10.25M - | 653K 93.63% | 251K 61.56% | 16.60M 6,511.95% | 7.16M 56.86% | 17.80M 148.57% | |
cash at end of period | 653K - | 251K 61.56% | 16.60M 6,511.95% | 7.16M 56.86% | 17.80M 148.57% | 13.01M 26.88% | |
operating cash flow | -10.31M - | -8.57M 16.89% | -17.70M 106.57% | -30.26M 70.91% | -39.03M 28.97% | -32.02M 17.94% | |
capital expenditure | -31K - | -53K 70.97% | -1.21M 2,175.47% | -2.03M 67.99% | -321K 84.16% | -180K 43.93% | |
free cash flow | -10.34M - | -8.62M 16.63% | -18.91M 119.28% | -32.28M 70.72% | -39.35M 21.87% | -32.20M 18.16% |
All numbers in USD (except ratios and percentages)